Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or ...
The Food and Drug Administration granted fast track designation to AUTX-703 for relapsed or refractory acute myelogenous ...
An expert explains that the GAP regimen did not improve overall survival in advanced biliary tract cancer versus the doublet ...
Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive ...
Odronextamab demonstrated a manageable safety profile and generated durable responses in patients with R/R DLBCL who have ...
Cancer tested my friendships by showing who could stay present through tough conversations, support me emotionally and endure pain together despite the loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results